Healthtech Startups

Enclony builds high-speed vision inspection systems for pharmaceutical manufacturing, used to inspect tablets, capsules, and tablet-capsule hybrids and to verify laser marking. Its equipment serves drug manufacturers requiring high-throughput quality inspection.

2 investors

Encuadrado is a practice management and payment platform for healthcare professionals and clinics in Chile, offering appointment scheduling, automated invoicing, and integrated payment processing. The platform serves individual practitioners and multi-disciplinary medical centers seeking to streamline administrative operations and financial management.

2 investors

Endless Health provides an all-in-one platform and strategic support for wellness professionals to launch and scale preventive health practices, combining precision lab testing, practice management software, and personalized coaching infrastructure.

2 investors

Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care. Par Health develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients with U.S.-based manufacturing capabilities.

2 investors

Endodiag develops non-invasive diagnostic tests based on blood biomarkers to identify endometriosis in women, addressing a condition currently requiring surgical diagnosis. The company also creates solutions to map patient disease for personalized treatment and fertility management.

2 investors

Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.

2 investors

Endor Health is building a modern, automated platform to help people living with diabetes access care and supplies. The company aims to simplify the fragmented experience of managing diabetes for the diabetes community.

2 investors

Abbott's cardiovascular division provides cardiac and vascular medical devices and technologies, including electrophysiology products for treating conditions such as AFib and remote hemodynamic monitoring for heart failure. It serves healthcare professionals with product, reimbursement, and training resources, as well as patients and caregivers.

2 investors

Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.

2 investors

Enflux produces motion capture clothing that tracks body movement, serving entertainment, fitness, and health applications through a platform with an open API.

2 investors

Company whose formation and launch the LifeSci team supported.

2 investors

Enhanced develops a scientific platform that combines sports performance analysis with human potential optimization. The company serves athletes and individuals seeking evidence-based approaches to safely enhance performance.

2 investors

Enlace Health provides a value-based care operating system, proprietary technology platform, and consulting services to help healthcare payors and providers manage specialty value-based care programs. It serves organizations navigating value-based healthcare transformation.

2 investors

Ennoble Care provides personalized in-home primary care, hospice, and palliative care services to patients. The company delivers compassionate healthcare focused on individualized patient support and well-being.

2 investors

Ennov provides an AI-powered unified compliance software platform for life sciences companies, covering regulatory, quality, clinical, pharmacovigilance, and commercial processes across the product lifecycle. Its solutions manage content, data, and workflows for regulated industries and are used by over 650 life sciences companies worldwide.

2 investors

Enrich Biosystems develops TROVO, a fluidics-free benchtop instrument that compartmentalizes standard culture plates into thousands of hydrogel microwells for high-throughput functional screening, imaging, and live recovery of cells. It serves cell therapy and life sciences researchers working on applications such as CAR-T cell selection, cell line development, and single-cell omics enrichment.

2 investors

Ensho is a biopharmaceutical company developing NSHO-101, an oral, selective small molecule α4β7 inhibitor intended as a once-daily treatment for patients with inflammatory bowel disease (IBD). The drug candidate, acquired from EA Pharma, is designed as an oral alternative to biologic therapies and as an anchor for oral combination therapy, and is currently in Phase 1 clinical development.

2 investors

Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment. The company develops an investigational neurostimulation device for post-stroke rehabilitation.

2 investors

Ensweet offers a cardiac telerehabilitation solution that lets patients follow their rehabilitation program at home while being monitored remotely by a multidisciplinary care team, via a web interface for clinicians and a mobile app for patients. Aimed at cardiovascular disease patients in France, its Ensweet Cardio product is a CE-marked medical device for hybrid and at-home cardiac rehabilitation.

2 investors

Entelexo develops engineered exosome therapeutics for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. The company uses a proprietary platform to design exosomes that communicate with multiple diseased cell types simultaneously, replacing traditional single-target treatments.

2 investors

EnteraSense is a medical device company that develops sensor-based diagnostic technology for gastrointestinal care, notably Pillsense, a tool to detect and monitor upper gastrointestinal bleeding. Founded in 2015, it works in partnership with Brigham and Women's Hospital/Harvard Medical School and serves clinical/healthcare providers.

2 investors

Enthea provides access to mental health treatment, including psychedelic-assisted therapy, positioned as a safe and affordable benefit for employers and healthcare consumers. The company serves corporate wellness programs, insurance plans, and health systems seeking to expand mental health treatment options.

2 investors

Entia develops at-home blood monitoring solutions for healthcare providers and patients. The company aims to reduce treatment burden and healthcare system disruption by integrating monitoring technology into daily life.

2 investors

Envirotainer provides temperature-controlled solutions for the pharmaceutical supply chain, serving healthcare providers and pharmaceutical distributors. The company offers tailored solutions across different stages of the pharmaceutical lifecycle.

2 investors